Wolverine Blend

Blend Cited range

ClassTwo-peptide repair blend

Typical routes in papersSC in community citations

Half-life contextPer component

EvidenceNo controlled trial of the combo; each piece has its own animal literature

What it is

Wolverine is a vendor nickname, not a unique molecule. Almost every listing means BPC-157 and TB-500 in one vial, most often 10 mg + 10 mg (20 mg total). Some shops add GHK-Cu and still call it Wolverine; that mix is closer to Glow. The name is comic-book marketing for “heal like Wolverine.”

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

What people want: one shot that covers local gut/tendon repair (BPC) and whole-body cell-migration (TB-500).
Typical vial: 10/10 mg. A 5/5 mg vial is the same ratio, half the material.
The combo itself has not been studied as a drug. Read the BPC-157 and TB-500 pages for the actual science.
If a label also lists GHK-Cu or KPV, you are looking at Glow, Klow, or Coremend — not classic Wolverine.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Side-by-side mechanisms, not a new receptor: BPC-157 is discussed for cytoprotection, NO/VEGF, and soft-tissue models; TB-500/TB4 for actin sequestration and cell migration. Mixing them does not create published synergy data.

Possible side effects / caveats

Same caveats as the parts: thin human safety, injection-site issues, unknown long-term angiogenesis talk. You cannot independently titrate one peptide if they are freeze-dried together.

Protocol ranges

Source tier	Amount	Frequency / duration	Notes
Common vendor vial	10 mg BPC-157 + 10 mg TB-500	Reconstitute; draw a fraction of the mixed solution	Ratio is fixed
Cited community range	Often ~250–500 mcg BPC + ~250–500 mcg TB per day equivalent	Daily or 5–7×/week for several weeks	Back-calculated from the blend, not a trial
See also	BPC-157 and TB-500 monographs		Single-agent pages

Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.